Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Neuberg Centre For Genomic Medicine, |
RCV003340831 | SCV004047592 | uncertain significance | Glanzmann thrombasthenia 1 | criteria provided, single submitter | clinical testing | The missense variant p.L940R in ITGA2B (NM_000419.5) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.L940R variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. There is a moderate physicochemical difference between leucine and arginine. The variant is predicted to be damaging by both SIFT and PolyPhen2. The residue is conserved across species. The amino acid change p.Leu940Arg in ITGA2B is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. |